These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3245358)

  • 21. Factors influencing the allergenicity and adjuvanticity of allergens.
    Deifl S; Bohle B
    Immunotherapy; 2011 Jul; 3(7):881-93. PubMed ID: 21751956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Specific experimental therapy in sensitization to group A streptococci].
    Nugmanova ZhS; Sukhodoeva GS; Beklemishev ND
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):120-5. PubMed ID: 352043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Control of the mutagenicity of a new immunomodulator].
    Volgareva GM; Savranskaia SIa; Tolcheev IuD; Anpilogova OR
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Mar; (3):56-61. PubMed ID: 2195812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The allergenic and immunotropic properties of the preparation pantohematogen].
    Ratner GM; Khlusova MIu; Stakheeva MN; Stepovaia EA; Sherstoboev EIu; Suslov NI
    Eksp Klin Farmakol; 1999; 62(6):56-8. PubMed ID: 10650530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergen Immunotherapy: Vaccine Modification.
    Creticos PS
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):103-24. PubMed ID: 26617230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity.
    Horner AA; Takabayashi K; Beck L; Sharma B; Zubeldia J; Baird S; Tuck S; Libet L; Spiegelberg HL; Liu FT; Raz E
    J Allergy Clin Immunol; 2002 Sep; 110(3):413-20. PubMed ID: 12209088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Allergenic character of tetrahydrocannabinol (delta 9 THC), active principle of Indian hemp (Cannabis saliva var. indica)].
    Lecorsier A; Hoellinger H; Nguyen-Hoang-Nam ; Fournier E
    C R Acad Hebd Seances Acad Sci D; 1977 Nov; 285(15):1351-3. PubMed ID: 414851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitizing and Th2 adjuvant activity of cysteine protease allergens.
    Cunningham PT; Elliot CE; Lenzo JC; Jarnicki AG; Larcombe AN; Zosky GR; Holt PG; Thomas WR
    Int Arch Allergy Immunol; 2012; 158(4):347-58. PubMed ID: 22472801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effector cells in allergy: biological principles and new pharmacologic concepts].
    Sperr WR; Agis H; Valenta R; Bankl HC; Sillaber C; Scheiner O; Kraft D; Lechner K; Valent P
    Wien Klin Wochenschr; 1993; 105(23):677-81. PubMed ID: 7508662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of Adjuvants for Enhancing Allergen Immunotherapy Efficacy.
    Chesné J; Schmidt-Weber CB; Esser von-Bieren J
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):125-45. PubMed ID: 26617231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bronchospasm mechanisms in experimental microbial sensitization. II. Pathochemical stage.
    Belyaev NN; Sukhodoeva GS; Beklemishev ND
    Allergol Immunopathol (Madr); 1984; 12(3):173-7. PubMed ID: 6206708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of allergen-specific desensitization.
    Uermösi C; Beerli RR; Bauer M; Manolova V; Dietmeier K; Buser RB; Kündig TM; Saudan P; Bachmann MF
    J Allergy Clin Immunol; 2010 Aug; 126(2):375-83. PubMed ID: 20624641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Formation of pollen-induced allergy in guinea pigs after specific immunotherapy with a bacterial allergen].
    Sukhodoeva GS; Bul'vakhter IaL; Nugmanova ZhS; Nugmanova DS
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):75-9. PubMed ID: 3765977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergen-loaded strontium-doped hydroxyapatite spheres improve allergen-specific immunotherapy in mice.
    Garbani M; Xia W; Rhyner C; Prati M; Scheynius A; Malissen B; Engqvist H; Maurer M; Crameri R; Terhorst D
    Allergy; 2017 Apr; 72(4):570-578. PubMed ID: 27590538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dynamics of the mast cell count and functional activity in the skin of guinea pigs as an index of mildly expressed allergic processes].
    Berezhnova LI; Petrova LP
    Vestn Dermatol Venerol; 1982; (12):56-60. PubMed ID: 7158018
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.
    Wanandy T; Dwyer HE; McLean L; Davies NW; Nichols D; Gueven N; Brown SGA; Wiese MD
    Clin Exp Allergy; 2017 Nov; 47(11):1478-1490. PubMed ID: 28756642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control Process for Manufacturing and Standardization of Allergenic Molecules.
    Carnés J; Iraola V; Gallego M; Leonor JR
    Curr Allergy Asthma Rep; 2015 Jul; 15(7):37. PubMed ID: 26143393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Allergenic effects of rubber adjuvants in animal experiments].
    Griepentrog F
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Feb; 130(2):180-9. PubMed ID: 4231550
    [No Abstract]   [Full Text] [Related]  

  • 39. [Specific hyposensitizing therapy of dermatoses with soluble bacterial allergens].
    Nureev GG
    Vestn Dermatol Venerol; 1982 Jul; (7):52-6. PubMed ID: 7136256
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunotherapy and mast cell activation.
    Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A
    Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.